openPR Logo
Press release

Inhaled Antibiotics Market to Surpass US$ 1,784.9 Mn by 2027

08-10-2020 01:34 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Coherent Market Insights

Inhaled Antibiotics Market

Inhaled Antibiotics Market

Global Inhaled Antibiotics Market, by Product Type (Aerosol, Dry Powder Formulation, and Spray), by Application (Pneumonia, Asthma, Bronchitis, and Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa), is estimated to be valued at US$ 1,160.69 million in 2020 and is projected to exhibit a CAGR of 6.3% over the forecast period (2020–2027), as highlighted in a new report published by Coherent Market Insights.

Key players operating in the global market are focused on adoption of inorganic growth strategies such as acquisition and collaboration, in order to expand its product portfolio and presence in the global market.

Request Sample Report + All Related Graphs & Charts @ https://www.coherentmarketinsights.com/insight/request-sample/3980

For instance, in April 2020, Savara Inc., a clinical-stage pharmaceutical company, entered into an exclusive license and collaboration agreement with Grifols S.A., a Spanish multinational pharmaceutical and chemical manufacturer company, to develop and commercialize Apulmiq (inhaled liposomal ciprofloxacin), also known as Linhaliq, in Europe. Apulmiq is a late-stage investigational inhaled antibiotic in phase 3 development for the treatment of non-cystic fibrosis bronchiectasis (NCFB).

Moreover, in February 2020, Grifols S.A., a Spanish multinational pharmaceutical and chemical manufacturer company, acquired Aradigm Corporation, a specialty pharmaceutical company. As a result of this acquisition, Grifols S.A. purchased Lipoquin, Free Ciprofloxacin, Apulmiq, and other antibiotic portfolio of Aradigm Corporation.

For instance, in September 2019, Portugal-based Hovione Technology, a company developing inhalation devices, entered into a collaboration agreement with the Kiel University’s Institute of Pharmacy in Germany. As a result of this agreement, the institution utilized Hovione’s portfolio of large dose dry-powder inhalers (DPIs) to conduct research on advanced formulation approaches for high-dose inhalation applications.

Players operating in the inhaled antibiotics market are facing major challenges on a number of fronts due to the COVID-19 pandemic. The major challenges include supply of raw materials such as APIs for antibiotics manufacturing due to irregularities in transportation facility, which will affect the global distribution channel. Moreover, patients are experiencing varying levels of demand due to increasing patient population suffering from respiratory diseases such as asthma, COPD, and novel COVID-19.

Moreover, patients with pre-existing medical history such as diabetes, severe asthma, and heart diseases are more vulnerable to COVID-19. There is concern that severe asthmatic patients with COVID 19 may have a worse outcome, however, there is no conclusive evidence to support this. Thus, high impact of coronavirus (Covid-19) pandemic globally is expected to limit growth of the global inhaled antibiotics market in the near future.

Increasing government initiatives for the development of novel products is expected to drive the market growth over the forecast period. For instance, in July 2018, the U.S. Food and Drug Administration held a public workshop on development of inhaled antibacterial drugs for cystic fibrosis and non-cystic fibrosis bronchiectasis. The purpose of the public workshop was to discuss the clinical trial design challenges and future considerations for inhaled antibacterial products to treat cystic fibrosis (CF) and non-CF bronchiectasis.

Request Sample copy @ https://www.coherentmarketinsights.com/insight/request-sample/3980

Coherent Market Insights 1001 4th Ave,
#3200 Seattle, WA 98154,U.S.
Phone: US +1-206-701-6702/UK +44-020 8133 4027
Email: sales@coherentmarketinsights.com

About Author:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help businesses around the globe deliver practical and lasting results through various recommendations about operational improvements, technologies, emerging market trends and new working methods.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Inhaled Antibiotics Market to Surpass US$ 1,784.9 Mn by 2027 here

News-ID: 2108335 • Views:

More Releases from Coherent Market Insights

Geriatric Care Services Market Size to Surge to US$ 784.7 million in Recording At A CAGR of 7.9% from 2024-2031 | Revera Inc., Senior Care Centers, Amedisys
Geriatric Care Services Market Size to Surge to US$ 784.7 million in Recording A …
Coherent Market Insights Published the Latest Geriatric Care Services Market Study by in-depth analysis of the current scenario, the Market size, demand, growth pattern, trends and forecast period 2024-2031. The Geriatric Care Services business report's clear, reliable, and thorough market data and information will undoubtedly aid in business development and boost return on investment (ROI). The region that is predicted to generate the greatest potential in the global Geriatric Care
Radioactive Tracer Market to Grow US$ 5.26 Bn by 2031 with a CAGR of 7.2% | Perk …
Coherent Market Insights Published the Latest Radioactive Tracer Market Study by in-depth analysis of the current scenario, the Market size, demand, growth pattern, trends and forecast period 2024-2031. The Radioactive Tracer business report's clear, reliable, and thorough market data and information will undoubtedly aid in business development and boost return on investment (ROI). The region that is predicted to generate the greatest potential in the global Radioactive Tracer market is
Non-Small Cell Lung Cancer Market Size & Share to Surpass US$ 49.11 Bn 2031, Projected a CAGR of 9.4% | F. Hoffmann-La Roche Ltd, Honeywell International Inc., AstraZeneca PLC
Non-Small Cell Lung Cancer Market Size & Share to Surpass US$ 49.11 Bn 2031, Pro …
Coherent Market Insights Published the Latest Non-Small Cell Lung Cancer Market Study by in-depth analysis of the current scenario, the Market size, demand, growth pattern, trends and forecast period 2024-2031. The Non-Small Cell Lung Cancer business report's clear, reliable, and thorough market data and information will undoubtedly aid in business development and boost return on investment (ROI). The region that is predicted to generate the greatest potential in the global
Atopic Dermatitis Market anticipated to reach a CAGR of 9.7% by 2031, Share, Size, Growth, Demand, and Segmentation Analysis| Pfizer Inc., Novartis AG, Nestle,
Atopic Dermatitis Market anticipated to reach a CAGR of 9.7% by 2031, Share, Siz …
Coherent Market Insights Published the Latest Atopic Dermatitis Market Study by in-depth analysis of the current scenario, the Market size, demand, growth pattern, trends and forecast period 2024-2031. The Atopic Dermatitis business report's clear, reliable, and thorough market data and information will undoubtedly aid in business development and boost return on investment (ROI). The region that is predicted to generate the greatest potential in the global Atopic Dermatitis market is

All 5 Releases


More Releases for Inhaled

Inhaled Corticosteroid Market Size, Share, Growth, Trends, Industry Forecast | V …
Inhaled Corticosteroid Market Asthma is a disease of the entire respiratory tract, including large, intermediate and small airways. Asthma led to inflammation and obstruction of the respiratory tract. Patients have various treatment options for asthma, particularly for young and elderly patients. Hence this has led to significant interest on the part of the inhaler device which is easy to use. Inhaled corticosteroid is the most commonly used tool for the
Inhaled NO Vasodilator Market: Competitive Dynamics & Global Outlook 2020-2025
Global Info Research offers a latest published report on Inhaled NO Vasodilator Analysis and Forecast 2020-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Inhaled NO Vasodilator Concentrate players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. Click to view the full report TOC, figure
Global Inhaled Antibiotics Market Huge Growth Opportunity between 2020-2025
LP INFORMATION recently released a research report on the Inhaled Antibiotics market analysis and elaborate the industry coverage, current market competitive status, and market outlook and forecast by 2025. Moreover, it categorizes the global Inhaled Antibiotics market by key players, product type, applications and regions,etc. The main objective of this market research is to help the readers understand the structure of Inhaled Antibiotics market, market definition, overview, industry opportunities and
Global Inhaled Antibiotics Market Size Analysis 2020-2025
GLOBAL INFO RESEARCHadded a new research report to its exhaustive repository. The research report, titled [Global and Japan Inhaled Antibiotics Market 2020 by Manufacturers, Type and Application, Forecast to 2025], presents an unbiased approach at understanding the market trends and dynamics. Analysts have studied the historical data pertaining to the market and compared it to the current market trends to paint an object picture of the market's trajectory. The report
New Concepts in Devices for Inhaled Medications Market 2017-2022
September Offer – Flat 20% discount on purchase of this report from 15th to 30th September @ https://www.researchtrades.com/discount/1228761 For more offers post 30th September, kindly contact us. Contact No. : +16269994607 (US)/ +91 7507349866 (IND) Email: sales@researchtrades.com Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Devices for Inhaled Medications in these regions, from 2012 to 2022 (forecast), covering North America Europe China Japan Southeast Asia India Ask
2017 Global Inhaled Nitric Oxide Sales Market- Inomax, Praxair, Air Liquide
Qyresearchreports include new market research report "Global Inhaled Nitric Oxide Sales Market Research Report 2017" to its huge collection of research reports. Global Inhaled Nitric Oxide research report is a dissertation on the global Inhaled Nitric Oxide market, filled with details that comprise the entirety of the market’s current status and future trajectory. The report has been designed in a way that will educate its readers on the positive and negative